Cysts - 80 Studies Found
Completed |
: Complete Twelve Month Bone Remodeling With a Bi-phasic Injectable Bone Substitute in Benign Bone Tumors : Bone Cyst : 2015-09-30 : Device: CERAMENT™ |BONE VOID FILLER Implantation of bi-phasic ceramic bone substitute to provide b |
Recruiting |
: Calcium Phosphate Cement Registry (CPC Registry) :
|
Completed |
: Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) :
: 2011-07-05 : Biological: MSV treatment Autologous maxillary bone marrow mesenchymal stem cells (MSV-H) collected from |
Enrolling by invitation |
: Gene-activated Bone Substitute for Maxillofacial Bone Regeneration :
|
Enrolling by invitation |
: Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects : Grafting, Bone : 2005-09-12 : Device: MBCP-Gel (tm) |
Completed |
: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face : Neoplastic Syndrome : 2007-06-20 : Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. |
Completed |
: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back : Skin Carcinoma : 2008-10-31 :
|
Withdrawn |
: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) : Basal Cell Carcinoma : 2010-07-06 :
|
Recruiting |
: Familial Investigations of Childhood Cancer Predisposition :
|
Completed |
: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients : Basal Cell Nevus Syndrome : 2016-04-27 :
|